|
|
|
Corporate Profile: Madeira Therapeutics
| Summary: |
| Madeira Therapeutics is focused on reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage. |
| Address (HQ): |
4745 W. 136th Street
Suite #102
Leawood, KS 66224 |
| Phone #'s (HQ): |
| Main |
(913) 661-1962 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(913) 451-5920 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
